physician photo

Joaquin Barnoya, MD, MPH

Assistant Professor

Learn more about Dr. Barnoya's research

Medical School

M.D., San Carlos University School of Medicine, Guatemala, 1998

Graduate School

M.P.H., Harvard School of Public Health, Boston, MA, 2001

Post Doctoral Education

Postdoctoral Fellow on Tobacco Control, University of California, San Francisco, CA, 2001-04

Honors and Awards

2005: National Cancer Institute “Redes en Accion”. “Rising Star in Cancer Research Award.”

2006: American Heart Association Top 10 Scientific Advances of 2005. “Cardiovascular Effects of Secondhand smoke: Nearly as Large as Smoking.” Circulation. 2005;111(20):3684-2698.

Research Interests

2009-11 International Development Research Center/Research for International Tobacco Control. “Tobacco control research mentorship program." PI

Biography

Dr. Joaquin Barnoya obtained his medical degree from San Carlos University Medical School in Guatemala in 1998. He then obtained a Masters in Public Health (emphasis in Family and Community Health) from the Harvard School of Public Health in Boston, MA. While at Harvard, he completed a two-year postdoctoral fellowship at the Department of Nutrition under the supervision of Dr. Graham Colditz, Dr.Ph. He then moved to the University of California, San Francisco, where he was a Legacy Foundation Tobacco Control research fellow under the supervision of Stan Glantz, Ph.D. After three years in San Francisco, he moved back to his native Guatemala where he serves as part-time Director of Research at the Cardiovascular Unit of Guatemala and practices preventive medicine. He is also a part-time Research Assistant Professor at the Department of Surgery, Washington University in St. Louis. Dr. Barnoya is also editor of the BMJ journal “Tobacco Control.” His research and publications focus on tobacco control, with particular emphasis on secondhand smoke effects, tobacco advertising and smoke-free workplaces.

Contact Information

660 S. Euclid Avenue
Campus Box 8100
St. Louis, MO 63110
(314) 362-0230
barnoyaj@wustl.edu

Selected Publications

First Author Peer Reviewed
Barnoya J, Mendoza-Montano C, Navas-Acien A. Secondhand smoke exposure in public places in Guatemala: Comparison with other Latin American countries. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2730-2735.

Barnoya J, Glantz S. Cardiovascular effects of secondhand smoke help explain the benefits of smoke-free legislation on heart disease burden. J Cardiovasc Nurs. 2006;21(6):457-462.

Barnoya J, Bialous SA, Glantz SA. Effective interventions to reduce smoking induced heart disease around the world: time to act. Circulation. 2005;112(4):456-458.

Barnoya J, Glantz SA. The tobacco industry's worldwide ETS consultants project: European and Asian components. Eur J Public Health. 2006;16(1):69-77.

Barnoya J, Glantz S. Cardiovascular effects of secondhand smoke: Nearly as large as smoking. 2004. Circulation. 2005;111(20):3684-2698.

Barnoya J, Glantz SA. Modifiable behavioral factors as causes of death. JAMA. 2004;291:2941-b-2942.

Other Peer Reviewed
Kummerfeldt CE, Barnoya J, Bero L. Philip Morris involvement in the development of an air quality laboratory in El Salvador. Tob Control. 2009;18:241-244.

Vida VL, Leon-Wyss J, Rojas M, Mack R, Barnoya J, Castañeda AR. Pulmonary artery hypertension: is it really a contraindicating factor for early extubation in children after cardiac surgery? Ann Thorac Surgery. 2006;81(4):1460-1465.

Vida VL, Calvimontes GS, Macs MO, Aparicio P, Barnoya J, Castañeda AR. Radiofrequency catheter ablation of supraventricular tachycardia in children and adolescents: feasibility and cost-effectiveness in a low-income country. Pediatr Cardiol. 2006;27(4):434-439.

Vida VL, Mack R, Barnoya J, Larrazabal LA, Lou R, Castaneda AR. The association of renal tubular acidosis and cyanotic congenital heart disease. J Thorac Cardiovasc Surg 2005;130(5):1466-1467.

Vida VL, Barnoya J, O'Connell M, Leon-Wyss J, Larrazabal LA, Castaneda AR. Surgical versus percutaneous occlusion of ostium secundum atrial septal defects: results and cost-effective considerations in a low-income country. J Am Coll Cardiol 2006;47(2):326-331.

Flores ML, Barnoya J, Mejia R, Alderete E, Perez-Stable EJ. Litigation in Argentina: challenging the tobacco industry. Tob Control. 2006;15(2):90-96.

Sebrie E, Barnoya J, Perez-Stable EJ, Glantz SA. Tobacco industry successfully prevented tobacco control legislation in Argentina. Tob Control. 2005;14(5):e2.

Vida VL, Barnoya J, Larrazabal LA, Gaitan G, de Maria Garcia F, Castaneda AR.Congenital cardiac disease in children with Down's syndrome in Guatemala. Cardiol Young 2005;15(3):286-290.

Bitton A, Neuman MD, Barnoya J, Glantz SA. The p53 Tumor suppressor gene and the tobacco industry: Research, debate, and conflict of interest 2004. Lancet. 2005;365(9458):531-540.

Pub Med for Joaquin Barnoya, M.D., M.P.H.

Editorial Positions

2009: Editorial Board Member: BMJ journal “Tobacco Control.”